What amount sold does OptoVista Holdings, LLC report in Form D filings?

The latest linked filings report $10.7M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was OptoVista Holdings, LLC's most recent SEC filing?

OptoVista Holdings, LLC's most recent Form D filing was on 2026-09-25.

How many investors does OptoVista Holdings, LLC have?

The most recent Form D filing lists 7 investor(s).

What type of securities does OptoVista Holdings, LLC offer?

OptoVista Holdings, LLC's SEC Form D filings indicate equity offerings.

OptoVista Holdings, LLC

CIK: 0002036372·Biotechnology·WASHINGTON, DC·Limited Liability Company·Founded 2023

Reported Sold

$10,706,331

Total Filings

Identified Offerings

Last Filed

Sep 25, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 25, 2026Form D — New notice

Reported sold: $3,727,518 · Target: $3,727,518

Rule 506(c)·7 investors

Sep 6, 2024Form D — New notice

Reported sold: $6,978,813 · Target: $13,978,813

Rule 506(c)·4 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$10,706,331

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Matthew Rosini

Related Person

Appears on 1 filing

Alexander Bailey

Related Person

Appears on 1 filing

Christina Ohnsman

Related Person

Appears on 1 filing

Steven Oliveira

Related Person

Appears on 1 filing

Kerry Propper

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 25, 2026	New	$3,727,518	$3,727,518	7
Sep 6, 2024	New	$13,978,813	$6,978,813	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

EVIA Life Sciences Inc.

Biotechnology

Offering target: $5,498,154

Filed Nov 2, 2026